SCHEMBL4368342

SCHEMBL4368342

CCCc1nn(Cc2ccc(Br)cc2F)c(=O)c(C(=O)OCC)c1O

nearest known ligand 0.55

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 6/20 0.55
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2C9 P11712 1/20 0.49
KMT2A Q03164 1/20 0.49
HSD17B10 Q99714 1/20 0.49
ALDH1A1 P00352 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ALOX5 P09917 5/20 0.40
PTGES O14684 2/20 0.40
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
PTGER1 P34995 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4360629 0.87 AKR1B1 (0.40) AKR1B1MEN1CYP1A2CYP2C9KMT2A
SCHEMBL3849074 0.85 AKR1B1 (0.50) AKR1B1MEN1CYP1A2CYP2C9KMT2A
SCHEMBL4357096 0.82 CYP19A1 (0.49) MEN1KMT2AALDH1A1SMN1; SMN2ALOX5
SCHEMBL4373002 0.82 AKR1B1 (0.55) AKR1B1MEN1CYP1A2CYP2C9KMT2A
SCHEMBL4364951 0.82 ALDH1A1 (0.45) MEN1KMT2AHSD17B10ALDH1A1SMN1; SMN2
SCHEMBL4362931 0.77 KDM4E (0.46) MEN1CYP1A2CYP2C9KMT2AHSD17B10
SCHEMBL11162987 0.76 AKR1B1 (0.74) AKR1B1MEN1CYP1A2CYP2C9KMT2A
SCHEMBL3851808 0.74 ALDH1A1 (0.42) AKR1B1MEN1CYP1A2CYP2C9KMT2A
SCHEMBL4360566 0.74 ALDH1A1 (0.40) MEN1KMT2AALDH1A1SMN1; SMN2MAPT
SCHEMBL11158759 0.74 AKR1B1 (0.60) AKR1B1MEN1CYP1A2CYP2C9KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2124565-A2 N-SUBSTITUTED GLYCINE DERIVATIVES: HYDROXYLASE INHIBITORS Smithkline Beecham Corporation (US) 2009-12-02 EP disclosed
WO-2008089052-A2 N-SUBSTITUTED GLYCINE DERIVATIVES: HYDROXYLASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2008-07-24 WO disclosed